Canada: Encouraging cost award trend emerging

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Canada: Encouraging cost award trend emerging

Enforcement of IP rights can sometimes culminate in litigation. In Canada, as in most jurisdictions, litigation related to IP is rarely inexpensive, with significant costs incurred for both counsel fees and for disbursements as varied as travel, scientific testing and the engagement of expert witnesses. Fortunately, in Canada successful parties are generally entitled to compensation for the costs of bringing their case. Indeed, most IP litigation in Canada occurs in the Federal Courts which have recently evinced an increasing willingness to ensure the adequacy of that compensation even in the most complex cases.

Canada's various courts usually provide some scheme for awarding costs. In the Federal Courts, cost awards include a component compensating for a portion of counsel fees and a component for reasonable and necessary disbursements. The fee component usually follows a tariff which sets out a range of set amounts for particular litigation activities and is intended to provide predictability while also accommodating varying degrees of case complexity. The fixed amounts are usually lower than actual costs and can be viewed as a compromise between compensating a successful party and not unduly burdening the other side.

The court is not, however, bound to apply the tariff and can choose to substitute a lump sum award proportionate to the counsel fees actually incurred by the prevailing party. Nonetheless, the tariff has typically been followed historically, with the complexity of cases such as those involving patents reflected in an award tending toward the higher end of the tariff.

Recently, however, a trend appears to be emerging where the Federal Court is shifting towards awarding lump sum costs that are higher than provided for under the tariff. The recent case of The Dow Chemical Company v Nova Chemical Corporation offers a prime example.

In that case, Dow alleged that the manufacture of certain polymers by Nova infringed a patent held by Dow. Nova counterclaimed alleging the patent was invalid. Ultimately, the court held that Dow's patent was both valid and infringed and that Dow was therefore entitled to remedies and an award of costs. In determining the latter, the Court considered the tariff but found that even its highest end would be "totally inadequate" in the circumstances of the case. The Court thus declined to follow the tariff and instead awarded Dow costs of C$6.5 million ($5 million), including a lump sum of C$2.9 million for legal fees and a further C$3.6 million for reasonable and necessary disbursements including certain in-house testing. The fee award was particularly significant and amounted to approximately 30% of Dow's actual counsel fees. The cost award was upheld on appeal.

This emerging trend is encouraging and may be an indication of a new willingness on the part of Canada's courts to provide adequate compensation for costs incurred by successful litigants in complex litigation such as the enforcement of IP rights.

Neil L Padgett


Smart & Biggar/ Fetherstonhaugh55 Metcalfe Street Suite 900PO Box 2999 Station DOttawa ON  K1P 5Y6Tel: 613 232 2486Fax: 613 232 8440 ottawa@smart-biggar.cawww.smart-biggar.ca

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article